Lincoln National Corp Medpace Holdings, Inc. Transaction History

Lincoln National Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$187.26 - $240.17 $64,604 - $82,858	-345 Reduced 3.25%	10,255 $2.46 Million
Q1 2023 May 01, 2023	BUY	$174.31 - $239.52 $1.22 Million - $1.67 Million	6,982 Added 192.98%	10,600 $1.99 Million
Q4 2022 Feb 07, 2023	BUY	$153.06 - $226.57 $553,771 - $819,730	3,618 New	3,618 $768,000
Q4 2018 Feb 08, 2019	SELL	$46.97 - $63.98 $339,593 - $462,575	-7,230 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$43.25 - $63.74 $312,697 - $460,840	7,230 New	7,230 $433,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.